Mark Slifka
President and CSO
Akorn
Romania
Biography
Dr. Slifka has served on academic review panels for the National Institutes of Health, Canadian Institutes of Health, Austrian Fund, Israel Science Foundation, Israel National Institute for Health Policy & Health Services, Wellcome Trust, Howard Hughes Medical Institute, the Institute of Medicine (IOM), and the Food & Drug Administration (FDA). This service, as well as the close association with academic research institutions, has played an important role in the early success of Najít Technologies by providing critical opportunities for advanced research collaborations. Dr. Slifka sets expansive goals for NTI’s vaccine development pipeline, identifying significant target pathogens and engaging a talented group of partners to advance these important vaccine programs.Dr. Slifka has published >80 research articles and reviews, including papers in prestigious biomedical journals such as Immunity, Nature, Nature Immunology, Nature Medicine, and the New England Journal of Medicine. He has been quoted in >200 news articles including leading newspapers such as USA Today and the Washington Post.
Research Interest
Immunology
